Lawsuit is part of a nationwide strategy by Novo Nordisk to protect its trademark and profits from its blockbuster GLP-1 ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

A survey reveals 25% of adults are considering using weight loss drugs without a prescription, raising concerns about safety ...

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell ...

U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they ...

At five feet, two inches tall, Julia O’Reilly was 190 pounds, prediabetic, and her blood pressure was elevated. Her only real ...

Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The ...

Chinese pharmaceutical and biotech companies are leading development of glucagon-like peptide-1 receptor agonists as Novo Nordisk A/S and Eli Lilly and Co. edge closer to launching blockbuster ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

Did she gain the weight back? Here's what she says, plus more mindful takeaways for the reported 15 million Americans who ...

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal ...